News UK trial 'could halve time to test Alzheimer's drugs' A pioneering UK study, AD-SMART, will test multiple repurposed and new drugs in parallel to try to slash the time it takes to gauge their efficacy.
News UK puts £80m behind dementia diagnosis push The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.
News UK needs 'clearer path for dementia diagnosis and treatment' UK Prime Minister Andy Burnham, who lost his father to Alzheimer's last week, has been urged to implement a "cancer-style" reform of dementia care.
News Major trial launched to explore GLP-1 benefit in dementia A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.
News GSK ends dementia alliance with Alector after setbacks GSK's alliance with Alector to develop two drug candidates for dementia has been terminated in the wake of disappointing clinical trial results.
News Almost half of dementia cases could be prevented, says study A study has found that nearly half of all cases of dementia are avoidable with lifestyle changes, but current education campaigns have limited effect.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.